Xeris Biopharma Holdings Inc (XERS)
3.305
+0.08
(+2.32%)
USD |
NASDAQ |
Nov 04, 13:15
Xeris Biopharma Holdings Market Cap: 492.44M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 481.27M |
| October 31, 2024 | 479.78M |
| October 30, 2024 | 481.27M |
| October 29, 2024 | 481.27M |
| October 28, 2024 | 481.27M |
| October 25, 2024 | 476.80M |
| October 24, 2024 | 482.76M |
| October 23, 2024 | 463.39M |
| October 22, 2024 | 449.98M |
| October 21, 2024 | 451.47M |
| October 18, 2024 | 455.94M |
| October 17, 2024 | 452.96M |
| October 16, 2024 | 452.96M |
| October 15, 2024 | 449.98M |
| October 14, 2024 | 442.53M |
| October 11, 2024 | 433.59M |
| October 10, 2024 | 414.22M |
| October 09, 2024 | 418.69M |
| October 08, 2024 | 438.06M |
| October 07, 2024 | 436.57M |
| October 04, 2024 | 444.02M |
| October 03, 2024 | 444.02M |
| October 02, 2024 | 433.59M |
| October 01, 2024 | 415.71M |
| September 30, 2024 | 424.65M |
| Date | Value |
|---|---|
| September 27, 2024 | 427.63M |
| September 26, 2024 | 421.67M |
| September 25, 2024 | 417.20M |
| September 24, 2024 | 420.18M |
| September 23, 2024 | 411.24M |
| September 20, 2024 | 436.57M |
| September 19, 2024 | 441.04M |
| September 18, 2024 | 432.10M |
| September 17, 2024 | 432.10M |
| September 16, 2024 | 429.12M |
| September 13, 2024 | 429.12M |
| September 12, 2024 | 426.14M |
| September 11, 2024 | 426.14M |
| September 10, 2024 | 403.79M |
| September 09, 2024 | 397.83M |
| September 06, 2024 | 373.99M |
| September 05, 2024 | 376.97M |
| September 04, 2024 | 393.36M |
| September 03, 2024 | 385.91M |
| August 30, 2024 | 418.69M |
| August 29, 2024 | 417.20M |
| August 28, 2024 | 415.71M |
| August 27, 2024 | 429.12M |
| August 26, 2024 | 432.10M |
| August 23, 2024 | 429.12M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
55.98M
Minimum
Mar 18 2020
492.44M
Maximum
Nov 04 2024
259.79M
Average
256.86M
Median
Sep 15 2020
Market Cap Benchmarks
| Zoetis Inc | 79.68B |
| Zevra Therapeutics Inc | 451.46M |
| NovaBay Pharmaceuticals Inc | 3.652M |
| Palatin Technologies Inc | 23.46M |
| iBio Inc | 23.67M |
Market Cap Related Metrics
| PS Ratio | 2.574 |
| Price | 3.305 |
| Earnings Yield | -12.71% |